Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katelyn F Handley

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
A Solution to the Dilution: The Role for Biomarkers in Advanced Ovarian CancerKatelyn F Handley, Anil K Sood
Ochsner Journal|January 7, 2021
Conservative Management of a Second-Trimester Cervical Ectopic PregnancyKatelyn F Handley, Lauren M Bergeron, Joseph R Biggio
Blood Advances|July 28, 2020
OvCa-Chip microsystem recreates vascular endothelium-mediated platelet extravasation in ovarian cancerBiswajit Saha, Tanmay Mathur, Katelyn F Handley, et al.
Gynecologic Oncology|February 11, 2020
Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trialRobert L Coleman, Katelyn F Handley, Robert Burger, et al.
Gynecologic Oncology|May 22, 2022
Frailty repels the knife: The impact of frailty index on surgical intervention and outcomesKatelyn F Handley, Anil K Sood, Graziela Zibetti Dal Molin, et al.
Cancer Medicine|August 8, 2024
Mechanism and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancerMark S Kim, Deanna Glassman, Katelyn F Handley, et al.
Molecular Cancer Therapeutics|June 6, 2020
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 InhibitorsTakahito M Miyake, Sunila Pradeep, Emine Bayraktar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2023
Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort studyKatherine I Foster, Katelyn F Handley, Deanna Glassman, et al.
Scientific Reports|April 25, 2025
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopyXiaotian Ma, Yu-Chun Hsu, Amma Asare, et al.
American Journal of Obstetrics and Gynecology|March 12, 2023
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumorsKatherine I Foster, Alejandra Flores Legarreta, Rhea Kamat, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
A Solution to the Dilution: The Role for Biomarkers in Advanced Ovarian CancerKatelyn F Handley, Anil K Sood
Ochsner Journal|January 7, 2021
Conservative Management of a Second-Trimester Cervical Ectopic PregnancyKatelyn F Handley, Lauren M Bergeron, Joseph R Biggio
Blood Advances|July 28, 2020
OvCa-Chip microsystem recreates vascular endothelium-mediated platelet extravasation in ovarian cancerBiswajit Saha, Tanmay Mathur, Katelyn F Handley, et al.
Gynecologic Oncology|February 11, 2020
Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trialRobert L Coleman, Katelyn F Handley, Robert Burger, et al.
Gynecologic Oncology|May 22, 2022
Frailty repels the knife: The impact of frailty index on surgical intervention and outcomesKatelyn F Handley, Anil K Sood, Graziela Zibetti Dal Molin, et al.
Cancer Medicine|August 8, 2024
Mechanism and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancerMark S Kim, Deanna Glassman, Katelyn F Handley, et al.
Molecular Cancer Therapeutics|June 6, 2020
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 InhibitorsTakahito M Miyake, Sunila Pradeep, Emine Bayraktar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2023
Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort studyKatherine I Foster, Katelyn F Handley, Deanna Glassman, et al.
Scientific Reports|April 25, 2025
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopyXiaotian Ma, Yu-Chun Hsu, Amma Asare, et al.
American Journal of Obstetrics and Gynecology|March 12, 2023
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumorsKatherine I Foster, Alejandra Flores Legarreta, Rhea Kamat, et al.
Pageof 2